AUROPHARMA

Wed, 5 Aug, 2026

• News

  Q1 results filed for Aurobindo Pharma

  ndtvprofit.com ↗
• FilingQ1 FY2027 financial results filed, period ended Jun 30, 2026NSE ↗
• Filing

  Q1 FY2026-27 unaudited financial results filed, first quarter since the last fiscal year

  NSE ↗
• Filing

  Aurobindo Pharma to merge two wholly owned stepdown subsidiaries with a wholly owned subsidiary

  NSE ↗
• Filing

  Board approved standalone and consolidated unaudited financial results for the period ending August 5, 2026

  BSE ↗
• FilingQ1 FY2027 financial results filed, first quarter since the IPO or listing announcementBSE ↗
• Filing

  Proposal to merge two wholly owned stepdown subsidiaries with a wholly owned subsidiary intimated under LODR Regulation…

  BSE ↗

Mon, 3 Aug, 2026

• Filing

  Integrated Annual Report 2025-26 filed under Reg. 34 (1)

  BSE ↗

Thu, 23 Jul, 2026

• FilingAurobindo Pharma acquires majority ownership in A1 Biochem Labs India and USANSE ↗
• Filing

  Acquisition of majority control in A1 Biochem Labs (India) Private Limited and A1 Biochem Labs LLC, USA

  BSE ↗

Tue, 21 Jul, 2026

• News

  Aurobindo Pharma subsidiary receives Brazil regulatory approval for Hyderabad biosimilars facility

  cnbctv18.com ↗
• FilingCuraTeQ Biologics subsidiary receives ANVISA approval for biosimilars manufacturing facilityNSE ↗
• Filing

  Curateq Biologics subsidiary receives ANVISA approval for biosimilar manufacturing facility

  BSE ↗

Fri, 10 Jul, 2026

• FilingAcquisition of a new stepdown subsidiary announced under LODR Regulation 30BSE ↗

Thu, 2 Jul, 2026

• Filing

  Aurobindo Pharma completes transfer of domestic branded generic formulations business to wholly owned subsidiary Auroph…

  NSE ↗
• FilingCompany completed transfer of domestic branded generic pharmaceutical formulations business to wholly owned subsidiary…BSE ↗

Tue, 30 Jun, 2026

• FilingAurobindo Pharma USA completes Lannett acquisition via wholly owned subsidiaryNSE ↗
• Filing

  Aurobindo Pharma USA Inc completes acquisition of Lannet

  BSE ↗

Sun, 28 Jun, 2026

• News

  Aurobindo's API unit cleared USFDA inspection with two observations reported in news

  business-standard.com ↗

Sat, 27 Jun, 2026

• News

  Aurobindo Pharma subsidiary completed US FDA inspection with two observations noted

  cnbctv18.com ↗